Mechanisms of Action of Potentilla discolor Bunge in Type 2 Diabetes Mellitus Based on Network Pharmacology and Experimental Verification in Drosophila
Yinghong Li,Fanwu Wu,Jianbo Zhang,Ye Xu,Hong Chang,Yueyue Yu,Chunhua Jiang,Xiujuan Gao,Huijuan Liu,Zhen Chen,Chenxi Wu,Ji-An Li
DOI: https://doi.org/10.2147/dddt.s439876
IF: 4.3188
2024-03-12
Drug Design Development and Therapy
Abstract:Yinghong Li, 1, &ast Fanwu Wu, 1, &ast Jianbo Zhang, 1 Ye Xu, 1 Hong Chang, 1 Yueyue Yu, 1 Chunhua Jiang, 1 Xiujuan Gao, 1 Huijuan Liu, 1 Zhen Chen, 2 Chenxi Wu, 1 Ji-An Li 1, 3 1 Hebei Key Laboratory of Integrated Traditional Chinese and Western Medicine for Diabetes and Its Complications, College of Traditional Chinese Medicine, North China University of Science and Technology, Tangshan, People's Republic of China; 2 Oriental Herbs KFT, Budapest, Hungary; 3 School of Public Health, North China University of Science and Technology, Tangshan, People's Republic of China &astThese authors contributed equally to this work Correspondence: Chenxi Wu; Ji-An Li, Tel +86-15930951086, Fax +86-03158805765, Email ; Purpose: Type 2 diabetes mellitus (T2DM) is associated with reduced insulin uptake and glucose metabolic capacity. Potentilla discolor Bunge (PDB) has been used to treat T2DM; however, the fundamental biological mechanisms remain unclear. This study aimed to understand the active ingredients, potential targets, and underlying mechanisms through which PDB treats T2DM. Methods: Components and action targets were predicted using network pharmacology and molecular docking analyses. PDB extracts were prepared and validated through pharmacological intervention in a Cg >InR K1409A diabetes Drosophila model. Network pharmacology and molecular docking analyses were used to identify the key components and core targets of PDB in the treatment of T2DM, which were subsequently verified in animal experiments. Results: Network pharmacology analysis revealed five effective compounds made up of 107 T2DM-related therapeutic targets and seven protein–protein interaction network core molecules. Molecular docking results showed that quercetin has a strong preference for interleukin-1 beta (IL1B), IL6, RAC-alpha serine/threonine-protein kinase 1 (AKT1), and cellular tumor antigen p53; kaempferol exhibited superior binding to tumor necrosis factor and AKT1; β-sitosterol demonstrated pronounced binding to Caspase-3 (CASP3). High-performance liquid chromatography data quantified quercetin, kaempferol, and β-sitosterol at proportions of 0.030%, 0.025%, and 0.076%, respectively. The animal experiments revealed that PDB had no effect on the development, viability, or fertility of Drosophila and it ameliorated glycolipid metabolism disorders in the diabetes Cg >InR K1409A fly. Furthermore, PDB improved the body size and weight of Drosophila , suggesting its potential to alleviate insulin resistance. Moreover, PDB improved Akt phosphorylation and suppressed CASP3 activity to improve insulin resistance in Drosophila with T2DM. Conclusion: Our findings suggest that PDB ameliorates diabetes metabolism disorders in the fly model by enhancing Akt activity and suppressing CASP3 expression. This will facilitate the development of key drug targets and a potential therapeutic strategy for the clinical treatment of T2DM and related metabolic diseases. Keywords: Potentilla discolor Bunge, T2DM, network pharmacology, molecular docking, Drosophila Graphical Diabetes mellitus (DM) is a persistent metabolic disorder characterized by elevated blood glucose levels, presenting a complex pathogenesis and substantial risks. 1 In particular, type 2 diabetes mellitus (T2DM) dominates, contributing to >90% of all diabetes cases through insulin resistance (IR) and β-cell dysfunction. 2 T2DM emerges when declining insulin efficacy triggers excess secretion, leading to hyperinsulinemia attributed to the mismatch between insulin resistance and inadequate compensatory insulin secretion. 3 Although conventional treatments like metformin, GLP-1 receptor agonists, and insulin mitigate T2DM, challenges such as drug resistance and adverse reactions, including weight gain, hypoglycemia, gastrointestinal effects, and cardiovascular disease, persist. Traditional Chinese medicine (TCM), featuring multi-link, -target, and -pathway activation mechanisms, has demonstrated notable therapeutic effects in T2DM, with an excellent safety profile, rendering it of high research value. Potentilla discolor Bunge (PDB) is a perennial herb belonging to the Rosaceae family with a broad distribution across Asia. It has a mild sweet-bitter taste. 4 It is typically used in traditional medicine for its anti-inflammatory, heat-clearing, and haemostatic effects. PDB is mainly utilised to treat carbuncles, sores, damp-heat diarrhoea, lung- -Abstract Truncated-
pharmacology & pharmacy,chemistry, medicinal